Shares

18 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2022

Nov 08, 2022

BUY
$29.83 - $38.01 $5,995 - $7,640
201 Added 9.14%
2,401 $77,000
Q2 2022

Aug 10, 2022

BUY
$23.09 - $33.46 $8,474 - $12,279
367 Added 20.02%
2,200 $65,000
Q1 2022

May 02, 2022

BUY
$26.91 - $47.15 $9,526 - $16,691
354 Added 23.94%
1,833 $52,000
Q4 2021

Feb 03, 2022

BUY
$32.97 - $56.85 $6,165 - $10,630
187 Added 14.47%
1,479 $68,000
Q3 2021

Nov 10, 2021

SELL
$26.48 - $35.99 $3,151 - $4,282
-119 Reduced 8.43%
1,292 $42,000
Q2 2021

Aug 06, 2021

BUY
$31.86 - $38.6 $3,982 - $4,825
125 Added 9.72%
1,411 $49,000
Q1 2021

May 13, 2021

BUY
$28.4 - $36.14 $2,470 - $3,144
87 Added 7.26%
1,286 $46,000
Q4 2020

Feb 12, 2021

BUY
$23.69 - $31.47 $1,137 - $1,510
48 Added 4.17%
1,199 $35,000
Q3 2020

Nov 13, 2020

BUY
$26.38 - $33.1 $18,228 - $22,872
691 Added 150.22%
1,151 $32,000
Q2 2020

Aug 06, 2020

BUY
$29.93 - $50.1 $1,586 - $2,655
53 Added 13.02%
460 $15,000
Q1 2020

May 11, 2020

BUY
$30.35 - $67.14 $2,245 - $4,968
74 Added 22.22%
407 $17,000
Q4 2019

Feb 11, 2020

SELL
$55.65 - $79.83 $612 - $878
-11 Reduced 3.2%
333 $21,000
Q3 2019

Nov 14, 2019

BUY
$64.7 - $85.39 $2,846 - $3,757
44 Added 14.67%
344 $25,000
Q2 2019

Aug 12, 2019

BUY
$67.77 - $82.2 $4,269 - $5,178
63 Added 26.58%
300 $25,000
Q1 2019

May 13, 2019

BUY
$45.83 - $70.54 $1,329 - $2,045
29 Added 13.94%
237 $17,000
Q4 2018

Feb 12, 2019

BUY
$41.17 - $56.44 $2,099 - $2,878
51 Added 32.48%
208 $9,000
Q3 2018

Nov 13, 2018

BUY
$52.95 - $71.34 $6,565 - $8,846
124 Added 375.76%
157 $9,000
Q2 2018

Aug 09, 2018

BUY
$56.38 - $68.08 $1,860 - $2,246
33 New
33 $2,000

Others Institutions Holding ANIP

About ANI PHARMACEUTICALS INC


  • Ticker ANIP
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—Specialty & Generic
  • Shares Outstandng 17,426,000
  • Market Cap $973M
  • Description
  • ANI Pharmaceuticals, Inc., a biopharmaceutical company, develops, manufactures, and markets branded and generic prescription pharmaceuticals in the United States and Canada. It focuses on producing controlled substances, oncology products, hormones and steroids, injectables, and other formulations. The company manufactures oral solid dose produc...
More about ANIP
Track This Portfolio

Track Mutual Of America Capital Management LLC Portfolio

Follow Mutual Of America Capital Management LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Mutual Of America Capital Management LLC, based on Form 13F filings with the SEC.

News

Stay updated on Mutual Of America Capital Management LLC with notifications on news.